Skip to content

D-peptide Immunotherapy for Treatment of Type 1 Diabetes (T1D)

A novel therapeutic approach for blocking HLA-DQ8 mediated antigen presentation in Type 1 Diabetes (T1D) via retro- inverso peptide

Published: 2nd October 2019
D-peptide Immunotherapy for Treatment of Type 1 Diabetes (T1D)
Please note, header image is purely illustrative. Source: Pablo.gainza, Wikimedia Commons, CC0
Seeking
  • Development partner
  • Commercial partner
  • Licensing